Registration Open: IHA-MAPS PSO Legal Webinar Sept. 22
All IHA members and Illinois healthcare providers are invited to join IHA and its component Patient Safety Organization (PSO), Midwest Alliance for Patient Safety (MAPS) PSO, for a free Sept. 22 legal webinar, “PSO Case Law Updates, CANDOR and Expanding the PSES,” from 10:55 a.m.-12:30 p.m. CT. Michael R. Callahan, JD, Senior Consultant at that Hardenbergh Group, will offer the latest information on PSO case law and challenges to federal protections.
Click here to register.
This is an excellent opportunity for internal and external legal counsel, risk management teams, quality and patient safety professionals, and other healthcare staff. Attend to earn up to 1.5 hours of nurse continuing education credit for this program or 1.5 hours of general Continuing Legal Education.
IHA’s MAPS is leading efforts to prevent medical error through resource sharing, education, and data collection and analysis. As a certified PSO since 2010, MAPS provides disclosure privileges, confidentiality and protections for reported patient events.
Click here to learn more about MAPS benefits.
ISMP Updates Guidelines to Address Medication Safety Risks
The Institute for Safe Medication Practices (ISMP) has updated guidelines in an effort to improve how medication information is communicated through electronic health records (EHRs). The revised “
Guidelines for Safe Electronic Communication of Medication Information,” last updated in 2019, reflects challenges with health information technology and aims to reduce medication errors in inpatient and outpatient settings
The new guidelines include recommendations for expressing drug names clearly, including the use of tall man lettering to help distinguish medications that look alike. In addition, the guidelines recommend improving drug search and selection errors and work to ensure essential information such as dosage route and form remains visible. The recommendations apply across all types of health IT systems used to manage medications, including EHRs, pharmacy platforms, e-prescribing systems and smart infusion pumps.
FDA Commissioner Announces Resolution of IV Saline Solutions Shortage
Today, Food and Drug Administration (FDA) Commissioner Marty Makary, M.D., M.P.H, issued a
statement to announce the end of the nationwide shortage of sodium chloride 0.9% injection products, a form of intravenous (IV) saline. These products will be removed from the FDA list of Current Shortages in the Drug Shortage Database on the FDA website. The FDA said it generally recommends hospitals, health systems, and clinics use the FDA-approved drug when available. For other IV fluids still in shortage, the FDA said it “is working closely with manufacturers and will continue to monitor the supply to help ensure patients have access to the medicines they need.”
CDC COCA Call: Clinician Update on U.S. Measles Cases and Outbreaks
This year, record-breaking numbers of U.S. measles cases and outbreaks have been reported, despite measles being declared eliminated in 2000. While the risk of widespread measles remains low for the general population due to high population-level immunity, measles importations continue to occur.
During a Centers for Disease Control and Prevention
Clinician Outreach and Communication Activity (COCA) Call, presenters will discuss the current epidemiology of measles in the United States and address the most common questions from clinicians about preventing, identifying, and testing for measles. Presenters will also summarize measles, mumps, and rubella (MMR) vaccination recommendations and considerations.
Click here to join the call on Thursday, Aug. 14 from 1-2 p.m. CT. Registration is not required.
If you are unable to attend the live session of this COCA Call, the closed-captioned video and transcript will be available on the
COCA Call webpage approximately one week after the live session. The slide deck will be available on the day of the call on the COCA Call webpage under “Webinar.” Free
Continuing Education credit will be offered for this COCA Call.
